Gene: NALF1
Official Full Name: NALCN channel auxiliary factor 1provided by HGNC
Gene Summary: Predicted to contribute to stretch-activated, monoatomic cation-selective, calcium channel activity. Predicted to be involved in calcium ion import across plasma membrane. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15884 | NALF1 Knockout cell line (HEK293) | Human | NALF1 | 1:3~1:6 | Negative | Online Inquiry |
NALF1 Gene Knockout Cell Lines are specialized cellular models engineered to lack the NALF1 gene, a critical component in various biological functions and pathways. These cell lines serve as invaluable tools for researchers investigating gene function, the underlying mechanisms of diseases, and the development of targeted therapies. The knockout of the NALF1 gene results in noticeable perturbations in cellular processes, allowing for in-depth studies of its role in cellular metabolism, proliferation, and differentiation.
These cell lines function by utilizing CRISPR-Cas9 gene editing technology, which allows for precise and efficient removal of the NALF1 gene. As a result of this modification, researchers can assess the phenotypic and genotypic changes that occur in the absence of NALF1, shedding light on its physiological and pathological implications. The ability to create these tailored cellular models accelerates research into conditions such as cancer, neurodegenerative disorders, and metabolic syndromes, offering potential breakthroughs in therapeutic development.
The scientific importance of NALF1 Gene Knockout Cell Lines lies in their versatility across various research disciplines, including pharmacology, molecular biology, and genetics. Compared to traditional gene knockdown strategies, knockout models provide a more complete loss-of-function analysis, yielding clearer insights into gene-specific roles. Moreover, their ease of use in standard laboratory protocols enhances reproducibility and scalability.
For researchers, clinicians, and biopharmaceutical companies, the NALF1 Gene Knockout Cell Lines represent a pivotal resource for elucidating complex biological questions and advancing medical research. By leveraging the specificity and reliability of these cell lines, users can streamline their experimental designs while generating robust data that informs future therapeutic strategies.
Our company prides itself on its expertise in developing high-quality biological products, including cell lines meticulously characterized to meet the evolving needs of the scientific community. With a commitment to innovation and excellence, we strive to empower researchers with the tools necessary to propel their work forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.